Cargando…
Obesity as a Prognostic Factor of Central Nervous System Relapse in Children with Acute Lymphoblastic Leukemia: A Single-Centre Study and Literature Review
Relapse as the commonest treatment failure through chemotherapy of child presented with acute lymphoblastic leukemia (ALL) is usually within 3 years of remission. Central nervous system (CNS) is expected as a site of extramedullary relapse in 3–8% of child leukemia, often leading to a poor prognosis...
Autores principales: | He, Guo-qian, Dai, Yi-ling, Jiang, Ming-yan, Gao, Ju, Guo, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959945/ https://www.ncbi.nlm.nih.gov/pubmed/35356245 http://dx.doi.org/10.1155/2022/7783823 |
Ejemplares similares
-
Isolated Central Nervous System Relapse of Acute Lymphoblastic Leukemia
por: Sung, Sang-Hyun, et al.
Publicado: (2014) -
Incidence and risk factors for central nervous system relapse in children
and adolescents with acute lymphoblastic leukemia
por: Cancela, Camila Silva Peres, et al.
Publicado: (2012) -
Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse
por: Gorshein, Elan, et al.
Publicado: (2018) -
Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021) -
Pattern and determinants of central nervous system relapse in childhood acute lymphoblastic leukemia in a resource-limited setting
por: Kulkarni, Ketan, et al.
Publicado: (2013)